Sai Life Sciences has opened Unit VI, a purpose-built veterinary API facility in Bidar, Karnataka, adjacent to the company’s flagship Unit IV API site. According to the company, the new plant is configured for stringent EHS practices and regulatory readiness to supply animal-health APIs at commercial scale. The unit will support global animal-health customers with…
India curbs COVID-19 vaccine exports as infections rise
After the number of COVID-19 infections began to incline steeply, India has decided to retain most of the vaccines produced in the country. The country has also announced plans to lower the eligibility requirements to all citizens 45 or older starting April 1. The Serum Institute of India is one of the world’s biggest vaccine…
India authorizes 2 COVID-19 vaccines
India is allowing reserved emergency use of the AstraZeneca (LON:AZN) COVID-19 vaccine and another from the domestic firm Bharat Biotech. The country is producing both vaccines internally. Serum Institute of India has a contract to manufacture the AstraZeneca vaccine and has stockpiled between 40 and 50 million doses. Covaxin, the vaccine from Bharat Biotech, was…